A New Solution For
VASCULAR DISEASE
A Large Global Challenge
Peripheral Artery Disease (PAD) is a significant and growing global issue, affecting over 20 Million people in the US, and over 200 Million people worldwide.
Here are some important points to note:
PAD and coronary arterial disease (CAD) are related. People with heart disease have a 1-in-3 risk of developing PAD
PAD can cause life-threatening critical limb ischemia which if not treated, can lead to amputation. The death rate after lower limb amputation is 48% at 1 year and a staggering 71% after 3 years
Percutaneous transluminal angioplasty (PTA) historically was the standard of care for treating PAD – there is a compelling need to minimize and limit the complications of PTA and improve long-term outcomes
- Effective plaque modification/vessel preparation is required to optimize and achieve consistent long-term outcomes following drug coated balloon (DCB) or drug-eluting stent (DES) therapies

A Large Global Challenge
Peripheral Artery Disease (PAD) is a significant and growing global issue, affecting over 20 Million people in the US, and over 200 Million people worldwide.
Here are some important points to note:
PAD and coronary arterial disease (CAD) are related. People with heart disease have a 1-in-3 risk of developing PAD
PAD can cause life-threatening critical limb ischemia which if not treated, can lead to amputation. The death rate after lower limb amputation is 48% at 1 year and a staggering 71% after 3 years
Percutaneous transluminal angioplasty (PTA) historically was the standard of care for treating PAD – there is a compelling need to minimize and limit the complications of PTA and improve long-term outcomes
- Effective plaque modification/vessel preparation is required to optimize and achieve consistent long-term outcomes following drug coated balloon (DCB) or drug-eluting stent (DES) therapies

people globally suffer from PAD
people in the US suffer from PAD
in the US are diagnosed with PAD every year
people globally suffer from PAD
people in the US suffer from PAD
in the US are diagnosed with PAD every year

Physicians seek to:
Improve long-term outcomes
Improve vessel compliance
Minimize vessel damage (barotrauma), reduce dissections and stenting, increase control & predictability
Improve therapy delivery to reduce revascularization rates



Physicians seek to:
Improve long-term outcomes
Improve vessel compliance
Minimize vessel damage (barotrauma), reduce dissections and stenting, increase control & predictability
Improve therapy delivery to reduce revascularization rates



Plaque modification / vessel prep prior to treatment optimizes outcomes
Preserve physicians’ choice of therapy
Seeking clinically effective, cost-efficient, easy-to-use options
Effective plaque modification prior to DCB therapy has potential to improve patient outcomes



Plaque modification / vessel prep prior to treatment optimizes outcomes
Preserve physicians’ choice of therapy
Seeking clinically effective, cost-efficient, easy-to-use options
Effective plaque modification prior to DCB therapy has potential to improve patient outcomes